QCOM down 7.6% on $4B Modular acquisition; LLY up 7.1% on Medicare drug coverage

$QCOM fell 7.6% after announcing a $4 billion acquisition of AI software startup Modular — a direct competitive challenge to Nvidia's dominant software stack for AI chips. The market read the price as steep for a software capability Qualcomm has not yet converted into revenue, and $AMAT dropped 6.2% alongside it, with no separate catalyst attached to the move.

Healthcare.

$LLY gained 7.1%. The catalyst is dateable: Medicare begins covering obesity drugs on July 1 with a $50 monthly copay for seniors, opening a new reimbursement channel on a government-mandated schedule. Lilly is also staging a European launch of its weight-loss franchise via telehealth in late 2026 and early 2027. Industry data shows dairy inventories down roughly 50% with prices doubled, a measure of how thoroughly obesity drug adoption is already reshaping consumer behavior and how large the addressable market has grown.

Enterprise software.

$MSFT added 5.7% without a separate headline catalyst. $CRM rose 5.4% after acquiring AI customer-service startup Fin for $3.6 billion — a response to competitive pressure from AI-native alternatives that analysts describe as a risk to legacy SaaS revenue. $PLTR gained 5.3% after Zeta Global announced a strategic partnership to deploy Palantir's platform for AI-powered marketing tools; separately, Michael Burry disclosed a reduction in his Palantir short position, which had been one of his larger disclosed bets. $ADBE was up 4.8%, supported by a $25 billion buyback program and AI revenue growing at more than 200% annually.

The rest of the session.

$COIN gained 4.6%; Bitcoin has been in slow decline through the first half of 2026, keeping transaction volumes compressed, and no specific catalyst was attached to the move. $NFLX added 4.1% after formalizing an AI-powered ad creative partnership with Omnicom Media — an incremental build for a streaming advertising business growing fast off a small absolute base. $JNJ rose 4.0% after winning a talc cancer lawsuit, though 67,000 additional cases remain pending, leaving the legal overhang materially intact.

Filings desk.

$AVGO director Henry Samueli sold $249.9 million in Broadcom stock. $ORCL's Vice Chairman exercised options and sold $47.3 million in shares. Neither transaction came with an accompanying material corporate disclosure.

What we set aside.

One ticker — $BRK-B — came through the sweep with no filings or substantive news in the window.

The desk is watching July 1: Medicare's formal obesity drug coverage start date, where the first enrollment and dispensing data will either validate $LLY's 7.1% move or begin to price in the gap between policy access and real-world uptake.